04 Aug 2026 Biovia launches six strategic Roadmaps to shape the future of health innovation Multiple categories
02 Apr 2026 SwiftPharma Expands R&D Footprint to Leuven in Strategic Co-Location with Benno Therapeutics Multiple categories
19 Feb 2026 SwiftPharma announces partnership with Medicines Patent Pool and Population Council on Project ELYRA to expand pathways for Griffithsin-based STI prevention Multiple categories
20 Dec 2021 argenx announces U.S. Food and Drug Administration (FDA) approval of VYVGART™ (efgartigimod alfa-fcab) in Generalized Myasthenia Gravis Member news
16 Nov 2021 New study demonstrates Idylla™ EGFR Mutation Test (CE-IVD) shortens time to patient management decisions for patients with non-small cell lung cancer Member news
More info? Ellen Telleir Communications Project Manager linkedin.com/in/ellentelleir/ ellen.telleir@biovia.be Contact us
